Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002530119 | SCV000650721 | likely benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821574 | SCV002068614 | likely benign | not specified | 2020-02-11 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002255152 | SCV002533116 | likely benign | Dyskeratosis congenita | 2021-07-13 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002255152 | SCV002718079 | likely benign | Dyskeratosis congenita | 2015-11-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004711170 | SCV005259072 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004543195 | SCV004771934 | likely benign | TERT-related disorder | 2021-10-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |